Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

A group has developed therapies that show promise for treating cancer and various other conditions.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

COVID-19 infection may trigger alopecia areata in some patients.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.